Benzinga | Nov 11, 2021 09:15AM EST

Unicycive Therapeutics Q3 EPS $(0.37) Down From $(0.08) YoY

Unicycive Therapeutics (NASDAQ:UNCY) reported quarterly losses of $(0.37) per share. This is a 362.5 percent decrease over losses of $(0.08) per share from the same period last year.